After participating in this educational activity, attendees should be able to:
1. Describe the mechanism of action of epoprostenol (Flolan, Veletri).
2. Discuss therapeutic considerations of epoprostenol in the critical care setting.
3. Review available evidence for inhaled epoprostenol administered through high-flow nasal cannula (HFNC).
Catherine Chatowsky, PharmD
PGY1 Pharmacy Resident
Baystate Medical Center
None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.
- 1.00 ACPE Contact Hours